FINWIRES · TerminalLIVE
FINWIRES

$SION

4 stories mentioning SION

Every FINWIRES story that references SION, newest first.

Sectors

Sector Update: Healthcare Stocks Advance Premarket Tuesday

Healthcare stocks were advancing premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.3% and the iShares Biotechnology ETF (IBB) 0.6% higher.Sionna Therapeutics (SION) shares were down more than 5% after the company reported a wider-than-expected Q1 net loss.Alkermes (ALKS) said a late-stage trial evaluating its investigational Lumryz oral suspension in adults with idiopathic hypersomnia, a rare condition in which patients require excessive sleep, met all primary and key secondary endpoints. Alkermes stock was up more than 2% pre-bell.BridgeBio Pharma (BBIO) shares were up more than 1% after the company said it has submitted a new drug application to the US Food and Drug Administration for encaleret, a potential treatment for autosomal dominant hypocalcemia type 1 (ADH1), a rare genetic condition affecting calcium levels.

$ALKS$BBIO$IBB$SION$XLV
Sectors

Sector Update: Healthcare

Healthcare stocks were up premarket Tuesday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.3% and the iShares Biotechnology ETF (IBB) 0.6% higher.Sionna Therapeutics (SION) shares were down 5% after the company reported a wider-than-expected Q1 net loss.

$SION
Research

Wedbush Initiates Sionna Therapeutics at Outperform With $53 Price Target

Sionna Therapeutics (SION) has an average rating of buy and mean price target of $50.60, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)

$SION
Insider Trading

Sionna Therapeutics Insider Sold Shares Worth $2,472,343, According to a Recent SEC Filing

Peter A. Thompson, Director, on April 17, 2026, sold 55,345 shares in Sionna Therapeutics (SION) for $2,472,343. Following the Form 4 filing with the SEC, Thompson has control over a total of 2,964,774 common shares of the company, with 2,964,774 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2036042/000094787126000459/xslF345X05/ownership.xml

$SION